A recent investigation has revealed that the flavor additives commonly found in e‑cigarettes can cause significant damage to joint tissue, even when nicotine is absent. Researchers at New Jersey’s Seton Hall University reported that cinnamon and menthol flavors trigger the death of ATDC5 cartilage cells, disrupt normal tissue repair and ignite inflammatory pathways that may accelerate musculoskeletal decline. The findings come as more than 7 % of American adults report regular use of e‑cigarettes, with an additional 8 % having vaped within the past week, according to federal and Gallup surveys. While vaping is still considered less harmful than combustible tobacco, health experts warn that the chemicals used to create appealing flavors can pose serious health risks, prompting calls for tighter scrutiny and clearer public‑health guidance.
How flavor chemicals affect joint and tissue health
The Seton Hall team focused on five popular e‑cigarette flavors—tobacco, strawberry‑kiwi, cinnamon, menthol and a neutral additive—to assess their impact on cellular health. Laboratory tests showed that cinnamon and menthol formulations caused ATDC5 cells, which are essential for cartilage formation, to die in large numbers. In addition, these flavor chemicals interfered with the cells’ capacity to build and maintain healthy tissue, leading to heightened inflammation and activating pathways that break down surrounding material. “Our findings show that e‑cigarette flavor additives are far from benign additives,” explained Jessica Cottrell, an associate professor at the university, in a statement. “Even without nicotine, these chemical agents alter metabolism, gene expression and inflammatory pathways, which underscores an urgent need to examine how vaping impacts broader musculoskeletal and tissue health.”
The study also highlighted that the damage is not limited to cartilage. The same flavor compounds were observed to provoke inflammatory responses in surrounding cells, setting off a cascade of biochemical changes that can lead to tissue swelling and eventual degeneration. This cellular stress mirrors early signs of osteoarthritis, a condition that affects millions and is typically associated with aging or joint injury. The researchers argue that the cumulative effect of regular vaping could therefore contribute to earlier onset of joint problems, a concern that extends beyond the lungs.
Wider research on the dangers of specific flavor compounds
The Seton Hall conclusions are supported by a growing body of independent research. Studies from Rutgers University and the University of Hawai‘i have identified cinnamaldehyde, a primary component of cinnamon flavoring, as a compound that can cause death in lung and respiratory cells. Similarly, menthol has been linked to adverse effects on airway epithelium, compounding the risk of respiratory irritation.
These investigations suggest that the perceived safety of vaping—often marketed as a cleaner alternative to smoking—may be misleading. While traditional cigarettes generate tar and carbon monoxide through combustion, e‑cigarettes deliver a cocktail of chemicals through aerosolisation. The flavor additives, heavy metals, volatile organic compounds and known carcinogens present in the vapour can all interact with human tissue in harmful ways. The American Heart Association has warned that the liquid used in these devices can be toxic if swallowed, inhaled or absorbed through the skin, a risk that extends to both adults and children.
Current usage patterns and regulatory context
Federal data released in March 2024 indicated that roughly 7 % of American adults reported being regular vapers, a figure that rose to 8 % when considering usage within the previous week, as captured by a 2025 Gallup poll. The popularity of flavored products remains a key driver of these statistics, with many users drawn to the taste experience rather than nicotine delivery alone.
Regulatory bodies have begun to respond, but gaps remain. In the United States, the Food and Drug Administration (FDA) has authority to regulate e‑cigarette products, yet enforcement actions have been uneven. Some states have introduced restrictions on certain flavorings, particularly menthol and fruit‑derived varieties, while others continue to allow a wide range of additives. Internationally, the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) classifies nicotine‑containing vaping products as medicinal products, requiring stricter safety assessments. However, the broader landscape of non‑nicotine flavor additives often falls through regulatory cracks, leaving consumers uncertain about the true safety of their choices.
Expert advice on reducing risk
Health professionals advise that anyone who vapes should consider a gradual reduction strategy, ideally with professional support. Switching to nicotine‑free devices can help eliminate exposure to the stimulant, but it does not remove the risk posed by flavor chemicals. For those seeking to quit altogether, nicotine‑replacement therapies approved by health authorities can provide a safer pathway, coupled with behavioural counselling.
Dr. Laura Simmons, a respiratory physician based in London, stresses that the damage caused by flavor additives is cumulative. “Even low‑level exposure over months can trigger inflammatory changes that may not be reversible,” she warns. “Patients who present with joint pain or early signs of respiratory irritation should be asked about vaping habits, and clinicians should be prepared to discuss cessation options.”
Public‑health campaigns are also shifting focus to educate users about the hidden dangers of seemingly harmless flavours. Visual campaigns that illustrate cellular damage, alongside clear labeling on packaging, are being piloted in several regions. Meanwhile, researchers continue to explore whether existing anti‑inflammatory medications could mitigate some of the tissue damage observed in vaping users.
Why it Matters
The emerging evidence that flavored vaping additives can impair cartilage and other tissues raises urgent questions about the long‑term health of millions of users, particularly young adults who may be more susceptible to cellular injury. As the popularity of e‑cigarettes remains high, policymakers, healthcare providers and manufacturers must act swiftly to close information gaps, strengthen regulation and provide clear guidance. Ignoring these risks could lead to a new wave of musculoskeletal and respiratory conditions, undermining public‑health gains achieved in other areas. Understanding and addressing the hidden hazards of vape flavors is therefore not just a medical imperative, but a societal one, ensuring that the pursuit of a “safer” nicotine alternative does not inadvertently cause other forms of harm.
